Literature DB >> 28054194

Ultrasound-based scores as predictors for nodular hyperplasia in patients with secondary hyperparathyroidism: a prospective validation study.

Jill Gwiasda1, Alexander Kaltenborn2,3, Jörg A Müller4, Michaela Serttas5, Georg W F Scheumann5, Harald Schrem2,5, Mark D Jäger5.   

Abstract

PURPOSE: Former studies evaluated echostructural and vascular patterns in ultrasound of the parathyroid gland to identify nodular hyperplasia in patients with secondary hyperparathyroidism due to chronic kidney disease. This prospective study aims to externally validate suggested ultrasound classifications.
METHODS: Parathyroid glands of 27 patients with secondary hyperparathyroidism undergoing parathyroidectomy were prospectively analyzed. Ultrasound including Doppler imaging was performed 1 day prior to surgery. Ultrasound data were available for 70 parathyroid glands. Echostructural and vascular scores according to previous studies were applied calculating the area under the receiver operating characteristic curve (AUROC). Overall correctness, sensitivity, and specificity of the investigated scores were assessed with the Youden index method.
RESULTS: The Doppler score introduced by Vulpio and colleagues based on characteristic blood flow patterns in parathyroid glands showed an AUROC of 0.749 for the prediction of nodular hyperplasia with an overall correctness of 72.8%. Other ultrasound classifications based on blood flow patterns, as well as echostructure of the parathyroid gland displayed AUROCs of <0.700, thus, lacking sufficient capability as a prognostic model. Overall correctness of prediction varied from 53.8 to 55.9%.
CONCLUSIONS: The Vulpio Doppler score for the prediction of nodular hyperplasia in patients with secondary hyperparathyroidism was externally validated for the first time. Other ultrasound scores fail as prognostic models in this study population. Doppler sonography of the parathyroid gland has prognostic capability to identify nodular hyperplasia as surrogate marker for patients with secondary hyperparathyroidism indicating the need for ablative or surgical treatment when failing conservative therapy.

Entities:  

Keywords:  Nodular hyperplasia; Parathyroid gland; Prognostic score; Secondary hyperparathyroidism; Ultrasound

Mesh:

Year:  2017        PMID: 28054194     DOI: 10.1007/s00423-016-1546-5

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  17 in total

1.  Presurgical setting of secondary hyperparathyroidism using high-resolution sonography and color Doppler.

Authors:  M Meola; I Petrucci; F Calliada; M Barsotti; M Puccini; M Grosso; G Barsotti
Journal:  Ultraschall Med       Date:  2010-04-22       Impact factor: 6.548

2.  Ultrasound patterns of parathyroid glands in chronic hemodialysis patients with secondary hyperparathyroidism.

Authors:  Carlo Vulpio; Maurizio Bossola; Annamaria De Gaetano; Giulia Maresca; Enrico Di Stasio; Pier Luigi Spada; Federica Romitelli; Giovanna Luciani; Marco Castagneto
Journal:  Am J Nephrol       Date:  2008-02-14       Impact factor: 3.754

3.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

Review 4.  Imaging of the parathyroid in chronic renal failure: diagnostic and therapeutic aspects.

Authors:  M Fukagawa; M Kitaoka; T Inazawa; K Kurokawa
Journal:  Curr Opin Nephrol Hypertens       Date:  1997-07       Impact factor: 2.894

5.  Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients.

Authors:  M Fukagawa; M Kitaoka; H Yi; N Fukuda; T Matsumoto; E Ogata; K Kurokawa
Journal:  Nephron       Date:  1994       Impact factor: 2.847

6.  Histology and immunohistochemistry of the parathyroid glands in renal secondary hyperparathyroidism refractory to vitamin D or cinacalcet therapy.

Authors:  Carlo Vulpio; Maurizio Bossola; Enrico Di Stasio; Luigi Tazza; Patrizia Silvestri; Guido Fadda
Journal:  Eur J Endocrinol       Date:  2013-04-29       Impact factor: 6.664

7.  Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation.

Authors:  Amin R Soliman; Hoda A Maamoun; Mahmoud A Soliman; Hatem Darwish; Esam Elbanna
Journal:  Rom J Intern Med       Date:  2016-09-01

8.  Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy.

Authors:  Yoshihiro Tominaga; Susumu Matsuoka; Tetsuhiko Sato; Nobuyuki Uno; Norihiko Goto; Akio Katayama; Toshihito Haba
Journal:  Ther Apher Dial       Date:  2007-08       Impact factor: 1.762

9.  Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism.

Authors:  Senji Okuno; Eiji Ishimura; Kayoko Kitatani; Hidenori Chou; Kyoko Nagasue; Kiyoshi Maekawa; Tsuyoshi Izumotani; Tomoyuki Yamakawa; Yasuo Imanishi; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Journal:  Nephrol Dial Transplant       Date:  2003-12       Impact factor: 5.992

Review 10.  Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement.

Authors:  G S Collins; J B Reitsma; D G Altman; K G M Moons
Journal:  Br J Surg       Date:  2015-02       Impact factor: 6.939

View more
  1 in total

1.  Therapeutic experience of severe and recurrent secondary hyperparathyroidism in a patient on hemodialysis for 18 years: A case report.

Authors:  Mingwen Zhu; Zongming Zhang; Fangcai Lin; Jieping Miao; Pei Wang; Chong Zhang; Hongwei Yu; Hai Deng; Zhuo Liu; Limin Liu; Baijiang Wan; Haiyan Yang; Mengmeng Song; Yue Zhao; Nan Jiang; Zichao Zhang; Zhenya Zhang; Lijie Pan
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.